List of Excipients in API adalimumab-bwwd
✉ Email this page to a colleague
Detailed excipient profiles for adalimumab-bwwd
Excipient focus: CITRIC ACID MONOHYDRATE
adalimumab-bwwd drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE
adalimumab-bwwd drug variants containing HISTIDINE
adalimumab-bwwd drug variants not containing HISTIDINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
adalimumab-bwwd drug variants containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
adalimumab-bwwd drug variants not containing HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
adalimumab-bwwd drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
adalimumab-bwwd drug variants containing POLYSORBATE 20
adalimumab-bwwd drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
adalimumab-bwwd drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
adalimumab-bwwd drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM SUCCINATE ANHYDROUS
adalimumab-bwwd drug variants containing SODIUM SUCCINATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing SODIUM SUCCINATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
adalimumab-bwwd drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCCINIC ACID
adalimumab-bwwd drug variants containing SUCCINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing SUCCINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
adalimumab-bwwd drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
adalimumab-bwwd drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | adalimumab-bwwd | 0006-5031 |
| >Company | >Ingredient | >NDC |
adalimumab-bwwd drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | adalimumab-bwwd | 50090-6704 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6705 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6706 |
| A-S Medication Solutions | adalimumab-bwwd | 50090-6707 |
| Organon LLC | adalimumab-bwwd | 78206-183 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
